Anggoro B Hartopo1, Dyah W Anggrahini1, Detty S Nurdiati2, Noriaki Emoto3,4, Lucia K Dinarti1. 1. Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health and Nursing Universitas Gadjah Mada and Dr Sardjito Hospital, Jogjakarta, Indonesia. 2. Department of Obstetry and Gynecology, Faculty of Medicine, Public Health and Nursing Universitas Gadjah Mada and Dr Sardjito Hospital, Jogjakarta, Indonesia. 3. Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan. 4. Laboratory of Clinical Pharmaceutical Science, Kobe Pharmaceutical University, Kobe, Japan.
Abstract
BACKGROUND: Pregnant uncorrected congenital heart disease patients, especially those who already developed pulmonary hypertension, have increased risk for maternal mortality. The pulmonary hypertension severity and right ventricle function may be associated with higher maternal mortality. The study aimed to investigate the mortality rate of pregnant uncorrected congenital heart disease and the impact of pulmonary hypertension severity on mortality. METHODS: This is the sub study of COngenital HeARt Disease in adult and Pulmonary Hypertension Registry. The data of pregnant uncorrected congenital heart disease patients were analyzed from registry database. The maternal mortality was recorded. The data of demography, clinics, obstetrics, and transthoracic echocardiography were collected. The factors that influenced maternal mortality were analyzed. A statistical significance was determined when p value < 0.05. RESULTS: From 2012 until 2017, there were 78 pregnant congenital heart disease patients. Of them, 56 patients were eligible for analyses. The majority of congenital heart disease was atrial septal defect (91.1%). The maternal mortality rate was 10.7% (6 of 56). Pulmonary hypertension occurred in 48 patients, therefore the maternal mortality rate among congenital heart disease-pulmonary hypertension with majority of atrial septal defect was 12.5% (6 of 48). Among nonsurvivors, 100% suffered from severe pulmonary hypertension as compared to survivors (56.0%), p = 0.041. Most nonsurvivors were Eisenmenger syndrome (83.3%), significantly higher compared to survivors (22.0%), p = 0.006. Nonsurvivors had significantly worsened WHO functional class, reduced right ventricle systolic function, and right heart failure. The modes of maternal death were severe oxygen desaturation (66.7%) and respiratory failure and sepsis (33.3%). Most of the maternal deaths occurred within 24 h postpartum period. CONCLUSION: Maternal mortality rate among pregnant uncorrected congenital heart disease with majority of atrial septal defect was 10.7% and among congenital heart disease-pulmonary hypertension with majority of atrial septal defect was 12.5%. Factors related with maternal mortality were severe pulmonary hypertension, Eisenmenger syndrome, and reduced right ventricle systolic function.
BACKGROUND: Pregnant uncorrected congenital heart disease patients, especially those who already developed pulmonary hypertension, have increased risk for maternal mortality. The pulmonary hypertension severity and right ventricle function may be associated with higher maternal mortality. The study aimed to investigate the mortality rate of pregnant uncorrected congenital heart disease and the impact of pulmonary hypertension severity on mortality. METHODS: This is the sub study of COngenital HeARt Disease in adult and Pulmonary Hypertension Registry. The data of pregnant uncorrected congenital heart disease patients were analyzed from registry database. The maternal mortality was recorded. The data of demography, clinics, obstetrics, and transthoracic echocardiography were collected. The factors that influenced maternal mortality were analyzed. A statistical significance was determined when p value < 0.05. RESULTS: From 2012 until 2017, there were 78 pregnant congenital heart disease patients. Of them, 56 patients were eligible for analyses. The majority of congenital heart disease was atrial septal defect (91.1%). The maternal mortality rate was 10.7% (6 of 56). Pulmonary hypertension occurred in 48 patients, therefore the maternal mortality rate among congenital heart disease-pulmonary hypertension with majority of atrial septal defect was 12.5% (6 of 48). Among nonsurvivors, 100% suffered from severe pulmonary hypertension as compared to survivors (56.0%), p = 0.041. Most nonsurvivors were Eisenmenger syndrome (83.3%), significantly higher compared to survivors (22.0%), p = 0.006. Nonsurvivors had significantly worsened WHO functional class, reduced right ventricle systolic function, and right heart failure. The modes of maternal death were severe oxygen desaturation (66.7%) and respiratory failure and sepsis (33.3%). Most of the maternal deaths occurred within 24 h postpartum period. CONCLUSION: Maternal mortality rate among pregnant uncorrected congenital heart disease with majority of atrial septal defect was 10.7% and among congenital heart disease-pulmonary hypertension with majority of atrial septal defect was 12.5%. Factors related with maternal mortality were severe pulmonary hypertension, Eisenmenger syndrome, and reduced right ventricle systolic function.
Authors: Willem Drenthen; Petronella G Pieper; Karin van der Tuuk; Jolien W Roos-Hesselink; Adriaan A Voors; Bianca Mostert; Barbara J M Mulder; Philip Moons; Tjark Ebels; Dirk J van Veldhuisen Journal: Eur Heart J Date: 2005-08-17 Impact factor: 29.983
Authors: Nazzareno Galiè; Marc Humbert; Jean-Luc Vachiery; Simon Gibbs; Irene Lang; Adam Torbicki; Gérald Simonneau; Andrew Peacock; Anton Vonk Noordegraaf; Maurice Beghetti; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; Georg Hansmann; Walter Klepetko; Patrizio Lancellotti; Marco Matucci; Theresa McDonagh; Luc A Pierard; Pedro T Trindade; Maurizio Zompatori; Marius Hoeper Journal: Eur Heart J Date: 2015-08-29 Impact factor: 29.983
Authors: A S Siegmund; M A M Kampman; M A Oudijk; B J M Mulder; G T J Sieswerda; S V Koenen; Y M Hummel; M W M de Laat; K M Sollie-Szarynska; H Groen; A P J van Dijk; D J van Veldhuisen; C M Bilardo; P G Pieper Journal: Ultrasound Obstet Gynecol Date: 2019-09 Impact factor: 7.299
Authors: Karen Sliwa; Iris M van Hagen; Werner Budts; Lorna Swan; Gianfranco Sinagra; Maryanne Caruana; Manuel Vazquez Blanco; Lodewijk J Wagenaar; Mark R Johnson; Gary Webb; Roger Hall; Jolien W Roos-Hesselink Journal: Eur J Heart Fail Date: 2016-07-07 Impact factor: 15.534
Authors: Vera Regitz-Zagrosek; Jolien W Roos-Hesselink; Johann Bauersachs; Carina Blomström-Lundqvist; Renata Cífková; Michele De Bonis; Bernard Iung; Mark Richard Johnson; Ulrich Kintscher; Peter Kranke; Irene Marthe Lang; Joao Morais; Petronella G Pieper; Patrizia Presbitero; Susanna Price; Giuseppe M C Rosano; Ute Seeland; Tommaso Simoncini; Lorna Swan; Carole A Warnes Journal: Eur Heart J Date: 2018-09-07 Impact factor: 29.983
Authors: Young Bin Song; Seung Woo Park; Jun Hyung Kim; Dae-Hee Shin; Sung Won Cho; Jin-Oh Choi; Sang-Chol Lee; Ju Ryoung Moon; June Huh; I-Seok Kang; Heung Jae Lee Journal: J Korean Med Sci Date: 2008-10 Impact factor: 2.153
Authors: Andriany Qanitha; Nurul Qalby; Muzakkir Amir; Cuno S P M Uiterwaal; Jose P S Henriques; Bastianus A J M de Mol; Idar Mappangara Journal: Glob Heart Date: 2022-09-13